The whole-process management of advanced non-small cell lung cancer according to the EGFR gene mutation state

聂小蒙; 白冲

doi:10.3969/j.issn.1007-3969.2015.05.014

您当前的位置：

首页 >

文章列表页 >

The whole-process management of advanced non-small cell lung cancer according to the EGFR gene mutation state

更新时间：2025-12-31

- The whole-process management of advanced non-small cell lung cancer according to the EGFR gene mutation state
- China Oncology Vol. 25, Issue 5, Pages: 397-400(2015)
- 作者机构：
  
  第二军医大学附属长海医院呼吸内科,上海,200433
- 作者简介：
- 基金信息：
- DOI：10.3969/j.issn.1007-3969.2015.05.014
  CLC：
- Published Online：11 August 2015，
  
  Published：11 August 2015
- 稿件说明：
移动端阅览
聂小蒙,白冲. 基于EGFR基因突变状态的非小细胞肺癌的全程化管理[J]. 中国癌症杂志, 2015, 25(5): 397-400.

聂小蒙, 白冲. The whole-process management of advanced non-small cell lung cancer according to the EGFR gene mutation state[J]. China Oncology, 2015, 25(5): 397-400.
聂小蒙,白冲. 基于EGFR基因突变状态的非小细胞肺癌的全程化管理[J]. 中国癌症杂志, 2015, 25(5): 397-400. DOI： 10.3969/j.issn.1007-3969.2015.05.014.

聂小蒙, 白冲. The whole-process management of advanced non-small cell lung cancer according to the EGFR gene mutation state[J]. China Oncology, 2015, 25(5): 397-400. DOI： 10.3969/j.issn.1007-3969.2015.05.014.

摘要

随着晚期非小细胞肺癌患者生存期的延长及治疗方法的增多，全程化管理的重要性日益凸显。本文按表皮生长因子受体(epidermal growth factor receptor，EGFR)基因突变状况不同，分别综述了EGFR基因突变阳性、阴性及未知的患者全程化管理策略。

Abstract

Along with prolongation of overall survival and increasing of therapeutic methods in advanced non-small cell lung cancer

whole-process management has become more and more important. We reviewed the wholeprocess management strategy according to difference of mutation state of epidermal growth factor receptor (EGFR) gene.

关键词

Keywords

references

Views

2233

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Clinical research progress of tumor mutational burden inEGFR-mutant advanced non-small cell lung cancer

The resistance mechanism and coping strategy of the third-generation EGFR-TKIs in NSCLC

Detection of EGFR gene mutations with mutation-specific immunohistochemistry in non-small cell lung cancer

Research on high-throughput detection of plasma cell-free DNA for targeted therapy-related genes screening and prognosis prediction in non-small cell lung cancer patients

Clinical pathological characteristics and immune microenvironment significance of EGFR T790M mutation in non-small cell lung cancer patients and its prognostic implications

Related Author

何　夕

焦晓栋

臧远胜

秦闪闪

常建华

张龙富

姚家美

蒋冬先

Related Institution

海军军医大学附属长征医院肿瘤科

复旦大学附属肿瘤医院肿瘤内科，复旦大学上海医学院肿瘤学系

复旦大学附属中山医院呼吸科

复旦大学附属中山医院病理科

Department of Molecular Diagnostics, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine

AI问答

⁰